VCMCVC Market Cap
Menu

Funding round

OpenEvidence Series B

OpenEvidence, which works in medical information search engine development in Miami, raised $210M in a Series B round announced on 17 Jul 2025, led by GV and Kleiner Perkins, at a $3.50B post-money valuation. 6 firms took part. It is OpenEvidence's second venture round on record; the one before was a Series A in Feb 2025.

$210M

Amount raised

$3.50B

Post-money valuation

$3.29B pre-money

6

Investors

2 leads

3.5x

Step-up from the Series A

$1.00B in Feb 2025

6.0%

Stake sold

new money over the post-money

Valuation

What this round says about the price

This round priced OpenEvidence at $3.50B after the new money, 3.5 times the $1.00B of its Series A (Feb 2025). The $210M bought investors about 6.0% of the company. It came 5 months after OpenEvidence's Series A. It is 29% of the $735M OpenEvidence has raised in the venture rounds on record. OpenEvidence raised again 3 months later: a Series C round of $200M in Oct 2025, at $6.00B post-money.

OpenEvidence's funding rounds

OpenEvidence has 4 venture rounds on record. This one is highlighted.

  1. Series A 1 Feb 2025, led by Sequoia Capital $75M$1.00B post-money
  2. Series B this round 17 Jul 2025, led by GV and Kleiner Perkins $210M$3.50B post-money
  3. Series C 20 Oct 2025, led by GV $200M$6.00B post-money
  4. Series D 6 Apr 2026, led by Thrive Capital and DST Global $250M$12.00B post-money

Investors

Who put money in

GV and Kleiner Perkins led the round with 4 other firms.

Lead investors

  • GV backs 428 venture-backed companies new investor
  • Kleiner Perkins backs 285 venture-backed companies new investor

Also in the round

  • Sequoia Capital backs 589 venture-backed companies new investor
  • Coatue backs 229 venture-backed companies new investor
  • backs 44 venture-backed companies new investor
  • Thrive Capital backs 130 venture-backed companies new investor

Use of proceeds

What the money is for

According to the announcement, the money goes to product development, scaling operations and working capital.

  • Product development
  • Scaling operations
  • Working capital

Comparable rounds

How it compares

666 Series B rounds in Tech Companies within a year either side disclosed an amount; the median was $34M, and this round was 6.2 times the median. The closest in time, other companies' Series B rounds in Tech Companies:

Series B rounds in Tech Companies, Jul 2024 to Jul 2026: 666 rounds with an amount, log scale.
Comparable rounds
CompanyAnnouncedAmountPost-moneyLed by
Tech Companies1 Jul 2025$5.30B$50.00BSequoia Capital
Tech Companies1 Jul 2025$160Mnot disclosedInsight Partners
Tech Companies22 Jul 2025$70Mnot disclosedLightrock and Partech
Tech Companies9 Jul 2025$55Mnot disclosedPeakSpan Capital
Tech Companies28 Jul 2025$50Mnot disclosedO.G. Venture Partners
Tech Companies24 Jul 2025$40M$325MInsight Partners
Tech Companies23 Jul 2025$38Mnot disclosedQED Investors
Tech Companies28 Jul 2025$37Mnot disclosedTheory Ventures

Sources

Where this comes from

Reported by 5 sources.

Questions

Frequently asked

How much did OpenEvidence raise in its Series B round?

OpenEvidence raised $210M in its Series B round, announced in Jul 2025.

Who led OpenEvidence's Series B round?

GV and Kleiner Perkins led it, with Sequoia Capital, Coatue, Conviction and Thrive Capital.

What was OpenEvidence's valuation at the Series B round?

$3.50B post-money ($3.29B pre-money).

How does it compare with other Series B rounds in Tech Companies?

666 Series B rounds in Tech Companies within a year either side disclosed an amount; the median was $34M, and this round was 6.2 times the median.

Did OpenEvidence raise again after this round?

Yes: a Series C round in Oct 2025 of $200M at $6.00B post-money.